For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Gencurix Inc

USPTO Granted Patents = 10

EPO Patents = 4

Trademarks = 2

Forward Citations = 5

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Young Kee Shin (10 out of 24 patents)

En Sel Oh (5 out of 5 patents)

Young Ho Moon (5 out of 7 patents)

4. Yong Ho In (3 out of 3 patents)

5. Mi Jeong Kwon (3 out of 3 patents)

6. Sang Seok Koh (3 out of 3 patents)

7. Jin Il Han (3 out of 3 patents)

8. Sang Rae Cho (3 out of 11 patents)

9. Young-Deug Kim (2 out of 5 patents)

10. Sang Rea Cho (2 out of 2 patents)

11. Jee Eun Kim (2 out of 3 patents)

12. Bohyun Byun (1 out of 1 patent)

13. Hyunjeung Choi (1 out of 1 patent)

14. Joon Seok Choi (1 out of 1 patent)

15. Myungsun Kim (1 out of 6 patents)

10 patents: Sort by Forward Citations

1. 11970732 - Method for determining nucleic acid quality of biological sample (2024-04-30),

2. 11840733 - Method for predicting prognosis of breast cancer patient (2023-12-12),

3. 11261482 - Composition for detecting epidermal cell growth factor receptor gene mutation, and kit comprising same (2022-03-01),

4. 11220716 - Methods for predicting the prognosis of breast cancer patient (2022-01-11),

5. 11107552 - Data processing, analysis method of gene expression data to identify endogenous reference genes (2021-08-31),

6. 10718030 - Methods for predicting effectiveness of chemotherapy for a breast cancer patient (2020-07-21),

7. 10655187 - Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof (2020-05-19),

8. 10428386 - Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same (2019-10-01),

9. 10304561 - Data processing, analysis method of gene expression data to identify endogenous reference genes (2019-05-28),

10. 9639660 - Data processing, analysis method of gene expression data to identify endogenous reference genes (2017-05-02),

Gencurix Inc is a leading biotechnology company specializing in molecular diagnostic solutions. With a focus on precision medicine, Gencurix develops innovative tests for cancer detection and personalized treatment. Their cutting-edge technologies enable healthcare professionals to make more informed decisions and improve patient outcomes. Gencurix is committed to advancing the field of molecular diagnostics and revolutionizing patient care.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#396 in Seoul

#1,086 in South Korea

#55,954 in the World

Seoul, South Korea

Gencurix Inc

Forward Citations = 5

22 inventors:

Young Kee Shin (10 out of 24 patents)

En Sel Oh (5 out of 5 patents)

Young Ho Moon (5 out of 7 patents)

4. Yong Ho In (3 out of 3 patents)

5. Mi Jeong Kwon (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…